Harvard Apparatus Regenerative Technology (Harvard Apparatus Regenerative Technology) Price-to-Operating-Cash-Flow : (As of May. 01, 2024)

View and export this data going back to 2013. Start your Free Trial

What is Harvard Apparatus Regenerative Technology Price-to-Operating-Cash-Flow?

As of today (2024-05-01), Harvard Apparatus Regenerative Technology's share price is $2.39. Harvard Apparatus Regenerative Technology's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was $-0.51. Hence, Harvard Apparatus Regenerative Technology's Price-to-Operating-Cash-Flow Ratio for today is .

The historical rank and industry rank for Harvard Apparatus Regenerative Technology's Price-to-Operating-Cash-Flow or its related term are showing as below:

HRGN's Price-to-Operating-Cash-Flow is not ranked ^*
in the Biotechnology industry.
Industry Median: 26.12
* Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.

Harvard Apparatus Regenerative Technology's Cash Flow from Operations per share for the three months ended in Dec. 2023 was $-0.09. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was $-0.51.

During the past 3 years, the average Operating Cash Flow per Share Growth Rate was -3.90% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 21.70% per year. During the past 10 years, the average Operating Cash Flow per Share Growth Rate was 38.60% per year.

During the past 13 years, Harvard Apparatus Regenerative Technology's highest 3-Year average Operating Cash Flow per Share Growth Rate was 57.80% per year. The lowest was -94.30% per year. And the median was 20.00% per year.

Harvard Apparatus Regenerative Technology Price-to-Operating-Cash-Flow Historical Data

The historical data trend for Harvard Apparatus Regenerative Technology's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Harvard Apparatus Regenerative Technology Price-to-Operating-Cash-Flow Chart

Harvard Apparatus Regenerative Technology Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Price-to-Operating-Cash-Flow

Get a 7-Day Free Trial

Harvard Apparatus Regenerative Technology Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Price-to-Operating-Cash-Flow	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Harvard Apparatus Regenerative Technology's Price-to-Operating-Cash-Flow

For the Biotechnology subindustry, Harvard Apparatus Regenerative Technology's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Harvard Apparatus Regenerative Technology's Price-to-Operating-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Harvard Apparatus Regenerative Technology's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Harvard Apparatus Regenerative Technology's Price-to-Operating-Cash-Flow falls into.

Harvard Apparatus Regenerative Technology Price-to-Operating-Cash-Flow Calculation

Harvard Apparatus Regenerative Technology's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio	=	Share Price	/	Cash Flow from Operations per share (TTM)
	=	2.39	/	-0.51
	=

Harvard Apparatus Regenerative Technology's Share Price of today is $2.39.
Harvard Apparatus Regenerative Technology's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.51.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio

Market Cap

Cash Flow from Operations

Harvard Apparatus Regenerative Technology Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Harvard Apparatus Regenerative Technology's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.

Harvard Apparatus Regenerative Technology (Harvard Apparatus Regenerative Technology) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Harvard Apparatus Regenerative Technology Inc (OTCPK:HRGN) » Definitions » Price-to-Operating-Cash-Flow

Comparable Companies

Traded in Other Exchanges

N/A

Address

84 October Hill Road, Suite 11, Holliston, MA, USA, 01746

Website

https://www.biostage.com

Harvard Apparatus Regenerative Technology Inc is a clinical-stage biotechnology company developing regenerative-medicine treatments for disorders of the gastrointestinal system and the airway resulting from cancer, trauma, or birth defects. The company's technology is based on its proprietary cell-therapy platform that uses a patient's own stem cells to regenerate and restore function to damaged organs.

Executives

Junli He	director	C/O NO.1, COUNTRY GARDEN ROAD, BEIJIAO TOWN, SHUNDE DISTRICT, FOSHAN F4 528300
James E. Shmerling	director	975 JOHNSON FERRY ROAD, SUITE 450, ATLANTA GA 30342
Dst Capital Llc	10 percent owner	C/O BIOSTAGE, INC., 84 OCTOBER HILL ROAD, HOLLISTON MA 01746
Ronald J Packard	director	2300 CORPORATE PARK DRIVE, HERNDON VA 20171
Jing Chen	director	C/O BIOSTAGE,INC., 84 OCTOBER HILL ROAD, HOLLISTON MA 02110
Hong Yu	officer: President	C/O BIOSTAGE, INC. 84 OCTOBER HILL ROAD, HOLLISTON MA 01746
Damasio Joseph Luis Jr	officer: Chief Financial Officer	14 NORFOLK AVENUE, SOUTH EASTON MA 02375
David Green	director, officer: See Remarks	C/O HARVARD BIOSCIENCE INC, 84 OCTOBER HILL ROAD, HOLLISTON MA 01746-1371
William Fodor	officer: Chief Scientific Officer	C/O BIOSTAGE, INC., 84 OCTOBER HILL ROAD, HOLLISTON MA 01746
Peter A. Pellegrino	officer: Interim VP of Finance	C/O BIOSTAGE, INC., 84 OCTOBER HILL ROAD, HOLLISTON MA 01746
Herman Sanchez	director	84 OCTOBER HILL ROAD, SUITE 11, HOLLISTON MA 01746
James Mastridge	officer: See Remarks	C/O BIOSTAGE, INC., 84 OCTOBER HILL RD., HOLLISTON MA 01746
Jeffrey E Young	director	60 WESTVIEW STREET, LEXINGTON MA 02421
Wei Zhang	director	C/O BIOSTAGE, INC., 84 OCTOBER HILL ROAD, HOLLISTON MA 01746
Ting Li	director	C/O BIOSTAGE, INC., 84 OCTOBER HILL RD., HOLLISTON MA 01746